Genomic characterisation of clinical and environmental Pseudomonas putida group strains and determination of their role in the transfer of antimicrobial resistance genes to Pseudomonas aeruginosa
Autor: | Silke Peter, Wichard Vogel, Leonard Schuele, Matthias Willmann, Daniela Dörfel, Ariane G Dinkelacker, Daniela Bezdan, Matthias Marschal, Philipp Oberhettinger, Jan Liese, Stephan Ossowski |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
BACTEREMIA lcsh:QH426-470 Gene Transfer Horizontal lcsh:Biotechnology OUTBREAK 030106 microbiology Virulence Biology Environment medicine.disease_cause SEQUENCE BLA(VIM-2) Microbiology 03 medical and health sciences VIM gene lcsh:TP248.13-248.65 Drug Resistance Bacterial INFECTION Genetics medicine Humans PHYLOGENETIC ANALYSIS MULTIDRUG-RESISTANCE Gene Phylogeny IDENTIFICATION Pseudomonas aeruginosa Pseudomonas putida Research Genomics Horizontal gene transfer biochemical phenomena metabolism and nutrition biology.organism_classification bacterial infections and mycoses Anti-Bacterial Agents Multiple drug resistance lcsh:Genetics VIM METALLO-BETA-LACTAMASE VIM-2 Mobile genetic elements Bacteria Biotechnology |
Zdroj: | BMC Genomics, 18:859. BioMed Central Ltd. Recercat. Dipósit de la Recerca de Catalunya instname BMC Genomics BMC Genomics, Vol 18, Iss 1, Pp 1-11 (2017) |
ISSN: | 1471-2164 |
Popis: | Pseudomonas putida is a Gram-negative, non-fermenting bacterium frequently encountered in various environmental niches. P. putida rarely causes disease in humans, though serious infections and outbreaks have been reported from time to time. Some have suggested that P. putida functions as an exchange platform for antibiotic resistance genes (ARG), and thus represents a serious concern in the spread of ARGs to more pathogenic organisms within a hospital. Though poorly understood, the frequency of ARG exchange between P. putida and the more virulent Pseudomonas aeruginosa and its clinical relevance are particularly important for designing efficient infection control strategies, such as deciding whether high-risk patients colonized with a multidrug resistant but typically low pathogenic P. putida strain should be contact isolated or not. In this study, 21,373 screening samples (stool, rectal and throat swab) were examined to determine the presence of P. putida in a high-risk group of haemato-oncology patients during a 28-month period. A total of 89 P. putida group strains were isolated from 85 patients, with 41 of 89 (46.1%) strains harbouring the metallo-beta-lactamase gene bla VIM. These 41 clinical isolates, plus 18 bla VIM positive environmental P. putida isolates, and 17 bla VIM positive P. aeruginosa isolates, were characterized by whole genome sequencing (WGS). We constructed a maximum-likelihood tree to separate the 59 bla VIM positive P. putida group strains into eight distinct phylogenetic clusters. Bla VIM-1 was present in 6 clusters while bla VIM-2 was detected in 4 clusters. Five P. putida group strains contained both, bla VIM-1 and bla VIM-2 genes. In contrast, all P. aeruginosa strains belonged to a single genetic cluster and contained the same ARGs. Apart from bla VIM-2 and sul genes, no other ARGs were shared between P. aeruginosa and P. putida. Furthermore, the bla VIM-2 gene in P. aeruginosa was predicted to be only chromosomally located. These data provide evidence that no exchange of comprehensive ARG harbouring mobile genetic elements had occurred between P. aeruginosa and P. putida group strains during the study period, thus eliminating the need to implement enhanced infection control measures for high-risk patients colonized with a bla VIM positiv P. putida group strains in our clinical setting. |
Databáze: | OpenAIRE |
Externí odkaz: |